choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • uniQure IPO

uniQure IPO Newsletter
  • The Daily Biotech Pulse: Amarin Vascepa Data, Galapagos Osteoarthritis Drug Update, 4 IPOs 16 Oct 2020 11:44 GMT

    … a strategic and corporate update) Uniqure NV (NASDAQ: QURE) Stocks In … L401 for infantile malignant osteopetrosis. IPOs Irvine, California-based Tarsus Pharmaceuticals … ophthalmic conditions, priced its upsized initial public offering, or IPO, of 5.5 million …

  • A Quick Investment Idea On uniQure 30 Jul 2020 20:45 GMT

    … development on June 24th. uniQure entered into an agreement with … Presentation The rights agreement provides uniQure with a $450 million … the parts valuation case for uniQure after this pullback. Source: … the Biotech Forum, Busted IPO Forum, and Insiders Forum …

  • Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 26 Jun 2020 12:22 GMT

    … primarily by biotech firms. IPO research firm Renaissance Capital says … million. —CSL Behring is paying uniQure (NASDAQ: QURE) $450 million … dose. THIS WEEK IN BIOTECH IPOS —Cambridge, MA-based Relay … a preliminary $100 million IPO goal. —Irish biopharma Amryt …

  • Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 23 Jun 2019 07:53 GMT

    … Sciences has reportedly postponed its IPO plans. —Gilead Sciences (NASDAQ: GILD … centering on gene therapy developer UniQure (NASDAQ: QURE), which is “exploring …

  • Report: uniQure Could Put Itself Up For Sale 17 Jun 2019 12:22 GMT

    uniQure NV (NASDAQ: QURE) shares are … options, including a potential sale. uniQure is a gene therapy company … The Radar Sorrento Therapeutics Could IPO Its Scilex Unit © 2019 Benzinga …

  • Want an insider’s way to play IPOs? This fund has had outsize success with its strategy 15 Apr 2019 13:02 GMT

    … participating in initial public offerings (IPOs), and often holding those positions … public “We evaluate almost every IPO that comes to market,” … Investors.Investors often think of IPO shares as hot commodities … 1.0% 32% 55% 439% UniQure NV QURE, -0.22% …

  • IPO Update: Hookipa Pharma Readies $100 Million IPO 08 Apr 2019 23:26 GMT

    … partnership with Gilead, and the IPO appears reasonably valued. Company … and was previously CEO at uniQure N.V. Hookipa has developed … Seeking Alpha Marketplace research service IPO Edge includes my full … and opinion on the IPO. Members of IPO Edge get the …

  • Hookipa Pharma Files Plan For U.S. IPO 28 Mar 2019 19:06 GMT

    … and was previously CEO at uniQure N.V. (NASDAQ:QURE). … the IPO price. Investor support is typical of successful life science IPOs … Seeking Alpha Marketplace research service IPO Edge includes my full … and opinion on the IPO. Members of IPO Edge get the latest …

  • The Daily Biotech Pulse: Big Miss For Seattle Genetics; Hematology Conference Presentations; Gossamer Bio, Harpoon IPOs 11 Feb 2019 10:20 GMT

    … Disorders, or EAHAD, Congress. Uniqure NV (NASDAQ: QURE) will … (before the market open) IPO Harpoon Therapeutics, an immuno-oncology … Bio priced its upsized IPO of 17.25 million … Conferences, Clinical Trials, Earnings And IPOs © 2019 Benzinga.com. Benzinga …

  • LogicBio IPO: Undervalued, But Phase 1/2 Clinical Trial Will Commence By The End Of 2019 16 Oct 2018 03:37 GMT

    … preferred stock outstanding after the IPO. The company expects to … securities right before the IPO goes live, which seems … expected capitalization after the IPO. Note that the expected … (BOLD) bluebird bio (BLUE) UniQure (QURE) Voyager Therapeutics (VYGR) …

Satisfied with the content?

Continue to create your account.